Today’s news coverage of the SEC’s decision to settle fraud charges against Theranos founder and CEO Elizabeth Holmes was marked by a somber tone, with the company releasing a simple statement saying it “is pleased to be bringing this matter to a close and looks forward to advancing its technology.” Holmes, who did not comment, paid a $500,000 penalty and agreed to a 10-year ban from serving as an officer or director in a public company.
What a difference a few years makes: When the Wall Street Journal‘s John Carreyrou wrote his first story back on October 16, 2015, raising doubts about the blood-testing company’s claims, the reaction was a lot different.
(31)